|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Rheumatoid Arthritis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Arthritis | |||||
| Arthritis, Rheumatoid | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Connective Tissue Diseases | |||||
| Immune System Diseases | |||||
| Joint Diseases | |||||
| Musculoskeletal Diseases | |||||
| Rheumatic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| ADL5859 | |||||
| naproxen | |||||
| Placebo | |||||
| Lactose monohydrate, NF | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-Inflammatory Agents | |||||
| Anti-Inflammatory Agents, Non-Steroidal | |||||
| Antirheumatic Agents | |||||
| Central Nervous System Agents | |||||
| Cyclooxygenase Inhibitors | |||||
| Enzyme Inhibitors | |||||
| Gout Suppressants | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Adolor Corporation | |||||